1. Home
  2. ARES vs IQV Comparison

ARES vs IQV Comparison

Compare ARES & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • IQV
  • Stock Information
  • Founded
  • ARES 1997
  • IQV 1982
  • Country
  • ARES United States
  • IQV United States
  • Employees
  • ARES N/A
  • IQV N/A
  • Industry
  • ARES Investment Managers
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • ARES Finance
  • IQV Health Care
  • Exchange
  • ARES Nasdaq
  • IQV Nasdaq
  • Market Cap
  • ARES 38.7B
  • IQV 31.0B
  • IPO Year
  • ARES 2014
  • IQV 2013
  • Fundamental
  • Price
  • ARES $183.46
  • IQV $187.57
  • Analyst Decision
  • ARES Buy
  • IQV Strong Buy
  • Analyst Count
  • ARES 15
  • IQV 20
  • Target Price
  • ARES $185.29
  • IQV $229.15
  • AVG Volume (30 Days)
  • ARES 1.4M
  • IQV 1.2M
  • Earning Date
  • ARES 10-31-2025
  • IQV 10-30-2025
  • Dividend Yield
  • ARES 2.42%
  • IQV N/A
  • EPS Growth
  • ARES N/A
  • IQV N/A
  • EPS
  • ARES 1.76
  • IQV 6.92
  • Revenue
  • ARES $4,827,669,000.00
  • IQV $15,700,000,000.00
  • Revenue This Year
  • ARES $19.11
  • IQV $6.01
  • Revenue Next Year
  • ARES $18.26
  • IQV $5.05
  • P/E Ratio
  • ARES $105.15
  • IQV $27.54
  • Revenue Growth
  • ARES 49.87
  • IQV 3.60
  • 52 Week Low
  • ARES $110.63
  • IQV $134.65
  • 52 Week High
  • ARES $200.49
  • IQV $248.03
  • Technical
  • Relative Strength Index (RSI)
  • ARES 54.46
  • IQV 52.51
  • Support Level
  • ARES $173.36
  • IQV $183.10
  • Resistance Level
  • ARES $181.86
  • IQV $191.86
  • Average True Range (ATR)
  • ARES 3.98
  • IQV 4.72
  • MACD
  • ARES 0.37
  • IQV -0.52
  • Stochastic Oscillator
  • ARES 82.10
  • IQV 70.44

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: